BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Posts about

uspto

stronger-patents-act

The STRONGER Patents Act: What You Need to Know

With concern growing about the United States’ ability to remain the dominant force in the global.

Read More
5G Profile Header

Everything is Connected: A Patent Perspective on 5G Technology

The next big technology shakeup is on its way. With a limited rollout in 2018 leading to a much.

Read More
Firms + Assignees Diff Examiners Blog Header

Which Firms and Companies Prosecute in Front of the Most Difficult Examiners? (2019)

We recently identified the ten most difficult examiners currently reviewing applications at the.

Read More
Most difficult examiners Blog Header

The Most Difficult Examiners at the USPTO (2019)

In an update to our 2016, 2017, and 2018 lists of most difficult examiners at the USPTO, we have.

Read More

USPTO Extends AFCP 2.0 Pilot Program Through September 30, 2020

The USPTO has announced its intention to extend the After Final Consideration Pilot (AFCP) 2.0.

Read More

Is Track One Still Worth It? Analysis Uncovers Five Key Trends

For patent applicants looking to move quickly, the USPTO's Track One program is a seemingly.

Read More

Beyond Allowance Rate: How to Highlight Firm Success at the USPTO

We often use allowance rate as a quick and simple way to quantify success at the USPTO -- and we.

Read More
Pfizer Mylan Header

Future of Pharma: The Pfizer / Mylan Merger

Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio.

Read More
Claims interpretation

USPTO Guidance for Claim Interpretation

The USPTO recently hosted a webinar about the general approach to interpreting claims and how.

Read More
UT _ Raytheon

Future of Defense: The United Technologies / Raytheon Merger

United Technologies, an American multinational conglomerate, recently agreed to combine its.

Read More

Are you ready to transform your patent practice?

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.